Concepedia

K C Goh

KC

3

Publications

421

Citations

3

H-Index

2011

Active since

Affiliations

Tan Tock Seng Hospital(Current)

K C Goh is an author at Tan Tock Seng Hospital specializing in jak-stat signaling pathway, immunology, and cell signaling.

Top concepts

Publications per year

2011–2012

3

Publications

3

SB1518, a novel macrocyclic pyrimidine-based JAK2 inhibitor for the treatment of myeloid and lymphoid malignancies

Stefan Hart, K C Goh, Veronica Novotny‐Diermayr et al. · Leukemia · 2011 · 195 citations · Full text

TG02, a novel oral multi-kinase inhibitor of CDKs, JAK2 and FLT3 with potent anti-leukemic properties

K C Goh, Veronica Novotny‐Diermayr, Stefan Hart et al. · Leukemia · 2011 · 128 citations

, , +9

The oral HDAC inhibitor pracinostat (SB939) is efficacious and synergistic with the JAK2 inhibitor pacritinib (SB1518) in preclinical models of AML

Veronica Novotny‐Diermayr, Stefan Hart, K C Goh et al. · Blood Cancer Journal · 2012 · 98 citations · Full text

, , +20

Rows per page

1–3 of 3